# Orchestration checkpoint — 2026-10-20

READY-01 audit candidate is on `launch/readiness-audit-v2-20261020`, based on selected integration commit `50403963d11cc51e6109a635f9a2b6b1031b8cf4`. The audit is provisional pending independent Astra review. See [readiness audit](readiness-audit-20261020.md) for evidence and limitations.

| Work | State | Model/effort | Checkout |
|---|---|---|---|
| Orchestrator | Active; accepted integration target branch `launch/implementation-20261020` created at selected base | User task settings | Primary checkout |
| READY-01 audit | Candidate committed; awaiting independent review | GPT-6 Luna / high | `C:/Users/erics/Documents/Projects/REMission-worktrees/readiness-audit-v2`, `launch/readiness-audit-v2-20261020` |
| G0 planning | Reserved, not yet assigned | GPT-6 Astra / medium | `C:/Users/erics/Documents/Projects/REMission-worktrees/g0-plan-20261020`, `launch/g0-plan-20261020`, selected base |
| G0 critique | Reserved, not yet assigned; must pin exact plan candidate before review | GPT-6 Astra / medium | `C:/Users/erics/Documents/Projects/REMission-worktrees/g0-critique-20261020`, detached at selected base |
| G0 contracts/implementation | Queued pending usable Sol slot/lifecycle | GPT-6.1 Sol / high | Not provisioned |

At the orchestrator's latest count: 0 open non-Luna workers, 1 spawned Luna helper, total spawned-thread capacity 3. Reserved Git worktrees are not counted as threads. Available controls observed include spawn, message, follow-up, interrupt, list, and wait; no close/release or model/effort change control is exposed. Completion/interruption is not evidence of release. Astra planning and critique fit the worker policy; subsequent Sol work must remain queued until the lifecycle/capacity blocker is resolved. Do not use top-level or nested tasks as a bypass.

Pending sequence: Astra G0 plan → independent Astra critique pinned to plan SHA → accept G0 package and ledger → Sol G0 contracts/implementation when an eligible slot is available → separate Astra review of exact Sol candidate. No engineering, human-factors, clinical-review, or clinical-validation gate has been accepted.
